title: Ractopamine, a livestock feed additive, is a full agonist at trace amine-associated receptor 1.
abstract: Ractopamine (RAC) is fed to an estimated 80% of all beef, swine, and turkey raised in the United States. It promotes muscle mass development, limits fat deposition, and reduces feed consumption. However, it has several undesirable behavioral side effects in livestock, especially pigs, including restlessness, agitation, excessive oral-facial movements, and aggressive behavior. Numerous in vitro and in vivo studies suggest RAC's physiological actions begin with its stimulation of β1- and β2-adrenergic receptor-mediated signaling in skeletal muscle and adipose tissue; however, the molecular pharmacology of RAC's psychoactive effects is poorly understood. Using human cystic fibrosis transmembrane conductance regulator (hCFTR) chloride channels as a sensor for intracellular cAMP, we found that RAC and p-tyramine (TYR) produced concentration-dependent increases in chloride conductance in oocytes coexpressing hCFTR and mouse trace amine-associated receptor 1 (mTAAR1), which was completely reversed by the trace amine-associated receptor 1 (TAAR1)-selective antagonist EPPTB [N-(3-ethoxyphenyl)-4-pyrrolidin-1-yl-3-trifluoromethylbenzamide]. Oocytes coexpressing hCFTR and the human β2-adrenergic receptor showed no response to RAC or TYR. These studies demonstrate that, contrary to expectations, RAC is not an agonist of the human β2-adrenergic receptor but rather a full agonist for mTAAR1. Since TAAR1-mediated signaling can influence cardiovascular tone and behavior in several animal models, our finding that RAC is a full mTAAR1 agonist supports the idea that this novel mechanism of action influences the physiology and behavior of pigs and other species. These findings should stimulate future studies to characterize the pharmacological, physiological, and behavioral actions of RAC in humans and other species exposed to this drug.
authors.affiliation: Department of Physiology and Pharmacology, School of Medicine (X.L., D.K.G.), Knight Cardiovascular Institute (D.K.G.), Research Service, Department of Veterans Affairs Medical Center, and Departments of Psychiatry and Behavioral Neuroscience (A.J.), and The Methamphetamine Abuse Research Center (D.K.G., A.J.), Oregon Health and Science University, Portland, Oregon liuxu@ohsu.edu.
authors.forename: Xuehong
authors.initials: X
authors.lastname: Liu
authors.affiliation: Department of Physiology and Pharmacology, School of Medicine (X.L., D.K.G.), Knight Cardiovascular Institute (D.K.G.), Research Service, Department of Veterans Affairs Medical Center, and Departments of Psychiatry and Behavioral Neuroscience (A.J.), and The Methamphetamine Abuse Research Center (D.K.G., A.J.), Oregon Health and Science University, Portland, Oregon.
authors.forename: David K
authors.initials: DK
authors.lastname: Grandy
authors.affiliation: Department of Physiology and Pharmacology, School of Medicine (X.L., D.K.G.), Knight Cardiovascular Institute (D.K.G.), Research Service, Department of Veterans Affairs Medical Center, and Departments of Psychiatry and Behavioral Neuroscience (A.J.), and The Methamphetamine Abuse Research Center (D.K.G., A.J.), Oregon Health and Science University, Portland, Oregon.
authors.forename: Aaron
authors.initials: A
authors.lastname: Janowsky
mesh_terms: D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005503:Food Additives / Q000494:pharmacology*; D006801:Humans; D008564:Membrane Potentials / Q000187:drug effects; D009865:Oocytes; D010627:Phenethylamines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology; D018343:Receptors, Adrenergic, beta-2 / Q000187:drug effects; D043562:Receptors, G-Protein-Coupled / Q000819:agonists* / Q000037:antagonists & inhibitors; D014439:Tyramine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014982:Xenopus laevis; D000095383:Trace Amine-Associated Receptors
chemical_list: D000318:Adrenergic beta-Agonists; D001549:Benzamides; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D005503:Food Additives; D010627:Phenethylamines; D011759:Pyrrolidines; D018343:Receptors, Adrenergic, beta-2; D043562:Receptors, G-Protein-Coupled; D014439:Tyramine; D000095383:Trace Amine-Associated Receptors; C505032:CFTR protein, human; C546333:N-(3-ethoxyphenyl)-4-pyrrolidin-1-yl-3-trifluoromethylbenzamide; C060897:ractopamine